The study clinical phenotypes of pulmonary hypertension due to left heart disease at preoperation time in patients with isolated mitral valve or simultaneous aortic and mitral valve replacement

  • Khuong Kieu Van 103 Millitary Medical Hospital
  • Thi Pham Thi Hong Viet Nam National Heart Institute

Main Article Content

Keywords

Pulmonary hypertension, left heart disease

Abstract

Objective: We aimed at describing the different haemodynamic phenotypes of patients with pulmonary hypertension (PH) due to left heart disease (LHD) before mitral valve replacement and/or concomitant aortic valve replacement and at characterizing the impact of pulmonary haemodynamics on RV function. Subject and method: 67 patients with pulmonary hypertension related left heart diseases who underwent elective (MVR) and/or aortic valve replacement (AVR) enrolled in this prospective study from April, 2017 to April, 2018 at Hue Heart Center. Result and conclusion: Prevalence of three subgroups of patients PH: Isolated post-capillary PH (Ipc-PH), combined post- and pre-capillary PH (Cpc-PH), intermediate PH (Interm-PH) are 43.2%, 28.4% and 28.4%, respectively. CpcPH presented with slightly higher weight and body mass index than intermediate patients (p<0.05). There was a significant difference in PAPs, PAPd, PAPm, TPG, DPG, PVR, SV, CI parameters across the three subgroups of PH-LHD. TAPSE showed a significantly difference between groups, while the ratio between TAPSE and systolic PAP progressively decreased from IpcPH to “intermediate” PH-LHD to CpcPH (p<0.0001).


 

Article Details

References

1. Caravita S, Faini A, Carolino D'Araujo S et al (2018) Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component. PLoS One 13(6): 1-16.
2. Dixon DD, Trivedi A, Shah SJ (2016) Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart Fail Rev 21(3): 285-297.
3. Naeije R, Gerges M, Vachiery JL et al (2017) Hemodynamic phenotyping of pulmonary hypertension in left heart failure. Circ Heart Fail 10(9): 1-10.
4. Palazzini M, Dardi F, Manes A et al (2018) Pulmonary hypertension due to left heart disease: Analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. Eur J Heart Fail 20(2): 248-255.
5. Mario Gerges, Christian Gerges, Anna-Maria Pistritto et al (2015) Pulmonary hypertension in heart failure: epidemiology, right ventricular function and survival. The American Thoracic Society: 1-50.
6. Drazner MH, Velez-Martinez M, Ayers CR et al (2013) Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail 6(2): 264-270.